James Gill, MD
Orthopaedic Surgery of the Spine · Omaha, NENPI 1962551440
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (40.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Medtronic at 54.7% of the total. Reporting peaked in 2023 at $1,783 and has fallen 93.3% since, to $119 in 2024.
Across 36 payments — averaging $116.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Globus Medical$2K
- Stryker$60
- Baxter Healthcare$48
- Augmedics Inc.$45
- Centinel Spine, LLC$24
- plus $84 from 5 others
What the payments were for
- Consulting fees$1,40033%
- Travel & lodging$1,09226%
- Food & beverage$1,71841%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 19 | $2,305 |
| Globus Medical(2 entities) | 6 | $1,643 |
| Stryker | 1 | $60 |
| Baxter Healthcare | 1 | $48 |
| Augmedics Inc. | 1 | $45 |
| Centinel Spine, LLC | 1 | $24 |
| Heron Therapeutics, Inc. | 1 | $22 |
| Surgalign Spine Technologies, Inc. | 2 | $21 |
| DJO, LLC | 1 | $19 |
| Si-bone, Inc. | 1 | $12 |
| Cerapedics Inc. | 2 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAZOR X SYSTEM$1,585
- Modulus$1,200
- TLIF$1,200
- XLIF$200
- STEALTHSTATION S8 PLATFORM$131
- Osteocel$125
How this compares
Too few orthopaedic surgery of the spine providers in Nebraskato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 109 | $1,533 |
| Gabapentin | 165 | $993 |
| Diclofenac Sodium | 79 | $791 |
| Pregabalin | 23 | $667 |
| Hydroxyzine Hcl | 46 | $607 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 32 | $452 |
| Celecoxib | 11 | $446 |
| Methylprednisolone | 43 | $285 |
| Cyclobenzaprine Hcl | 13 | $96 |
| Tramadol Hcl | 21 | $75 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery of the spine in Omaha
- Travis BaileyOmaha$7K
- Chase WoodwardOmaha$6K
- Timothy BurdOmaha$4K
- John McClellanOmaha$4K
- Adam SchellOmaha$3K
- Eric PhillipsOmaha$2K
- Michael LongleyOmaha$1K
- Johnathan FullerOmaha$470
- Geoffrey McCullenLincoln$39K
- David BenavidesKearney$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.